U.S. Defense Secretary Pete Hegseth directed annual testosterone-deficiency screening for active-duty and reserve service members age 30 and older, with voluntary treatment options. The order coincides with reversal of a prior flu vaccine mandate and changes at the Department of Health and Human Services to its vaccine advisory panel and recommendations. Five of six men's health experts contacted by Reuters expressed puzzlement over the screening directive.